Individual profiling of circulating tumor cell composition in patients with non-small cell lung cancer receiving platinum based treatment.

Abstract

Our data suggest that different CTC populations are identifiable in peripheral blood and that these individual cell type profiles might be used to predict outcome to platinum based systemic therapies in lung cancer patients.